U.S., March 10 -- ClinicalTrials.gov registry received information related to the study (NCT07458542) titled 'Effectiveness and Safety of ONUREG (Oral Azacitidine) in Chinese Patients With Acute Myeloid Leukemia' on Feb. 25.
Brief Summary: The purpose of this study is to assess real-world effectiveness and safety of oral azacitidine in adults diagnosed with acute myeloid leukemia (AML) in Hong Kong
Study Start Date: Dec. 09, 2025
Study Type: OBSERVATIONAL
Condition:
Acute Myeloid Leukemia (AML)
Intervention:
DRUG: Azacitidine
According to the product label
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Bristol-Myers Squibb
Published by HT Digital Content Services with permission from Health Daily Digest....